When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CASI - CASI Pharma in-licenses rights to TSK011010 from Black Belt Therapeutics; shares up 5% premarket
CASI Pharmaceuticals Inc.
CASI Pharmaceuticals (NASDAQ:CASI) has signed a license agreement for exclusive worldwide rights to investigational anti-CD38 monoclonal antibody (Mab) TSK011010 program from Black Belt Therapeutics Limited.
More news on: CASI Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,